Evaluation of Rosiglitazone Anti-inflammatory Effect With FDG-PET Imaging

Clinical trial NCT01174056 · COMPLETED

Trial details

NCT number: NCT01174056
Sponsor: Washington University School of Medicine
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Lung Inflammation

Start date: 2011-07-01
Primary completion: 2014-03-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.